Transaction · 0001520262-26-000004

Hopkinson Craig C.

Hopkinson Craig C., ER, D, CMO, reported a transaction classified as exercise at Alkermes plc. involving 5000.000000 shares for an estimated $96700.00. Reported holdings after the transaction were 66740.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MER, D, CMO
ALKSAlkermes plc.
Filing timeJan 08
Trade dateJan 08, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ALKS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ALKS since 2026-01-08Filed 239 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001520262-26-000004
Ordinary Shares
Transaction date
Jan 08, 2026
Filed Jan 08, 2026, 10:23 PM · 0d delay
Shares
5.00k sh
$1.93k per share
Estimated value
$9.67M
Computed from shares × price
Holdings after
66.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP R&D, Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

  2. F2

    This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.

  3. F3

    The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.01. Full information regarding the number of shares sold…

  4. F4

    These options are fully vested in accordance with their terms.

Original filing · 0001520262-26-000004
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ALKS